Okta, Inc. is rated a Buy with compelling growth opportunity amid expensive large-cap valuations. Learn more about OKTA stock ...

CYB003/CYB004 clinical catalysts into 2026, $248M cash runway, equity raises risk, valuation optionality. Click for this CYBN ...

The United States stands as the global hub of technological innovation, hosting some of the most influential Information ...

Puma works on iPhone and Android, providing you with secure, local AI directly in your mobile browser. Follow ZDNET: Add us as a preferred source on Google. Puma Browser is a free mobile AI-centric ...

California's DROP program is now active, giving residents the ability to stop data brokers from selling their personal ...

Here's a look at the notable projects that went before local planning commissions in December for various stages of approval.

The Delete Request and Opt-out Platform (DROP) will force registered data brokers to delete your personal data upon request.

While UnitedHealth Care dominated health news headlines during 2025, excess mortality was the biggest health story of the year.